The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity
Abstract
Human papillomaviruses (HPVs) are small double‐stranded DNA viruses that infect the cutaneous and mucosal epithelium. Infection by specific HPV types has been linked to the development of cervical carcinoma. HPV infects epithelial cells that undergo terminal differentiation and so encode multiple mechanisms to override the normal regulation of differentiation to produce progeny virions. Two viral proteins, E6 and E7, alter cell cycle control and are the main arbitrators of HPV‐induced oncogenesis. Recent data suggest that E6 and E7 also play a major role in the inhibition of the host cell innate immune response to HPV. The E1 and E2 proteins, in combination with various cellular factors, mediate viral replication. In addition, E2 has been implicated in both viral and cellular transcriptional control. Despite decades of research, the function of other viral proteins still remains unclear. While prophylactic vaccines to block genital HPV infection will soon be available, the widespread nature of HPV infection requires greater understanding of both the HPV life cycle as well as the mechanisms underlying HPV‐induced carcinogenesis. Copyright © 2005 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Papillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Estimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Boring, C. C., Squires, T. S., Tong, T., & Montgomery, S. (1994) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.44.1.7 · Cited by 1,315
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206 · cited 1×
“In addition to extending the life of epithelial cells for production of viral progeny, this effect also influences HPV-induced carcinogenesis as overexpression of hTERT in conjunction with E7 expression has been shown to be sufficient to immortalise human primary keratinocytes [64].”
BackgroundEpidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,068
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879
Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population
Pisani, P., Bray, F., & Parkin, D. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.1571 · Cited by 730
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 660
Chellappan, S., Kraus, V. B., Kroger, B., Munger, K., Howley, P. M., Phelps, W. C., & Nevins, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4549 · Cited by 614
Jeon, S., Allen-Hoffmann, B. L., & Lambert, P. F. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2989-2997.1995 · Cited by 582
Host defense, viruses and apoptosis
Barber, G. N. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400823 · Cited by 582
Ronco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 544
zur Hausen, H., & de Villiers, E.-M. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.002235 · Cited by 474
Structure of Small Virus-like Particles Assembled from the L1 Protein of Human Papillomavirus 16
Chen, X. S., Garcea, R. L., Goldberg, I., Casini, G., & Harrison, S. C. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80449-9 · Cited by 471
Induction and Regulation of IFNs During Viral Infections
Malmgaard, L. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/1079990041689665 · Cited by 454
Ustav, M., & Stenlund, A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07967.x · Cited by 448
Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., & Ishibashi, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11612 · Cited by 428
Funk, J. O., Waga, S., Harry, J. B., Espling, E., Stillman, B., & Galloway, D. A. (1997) · Genes & Development · doi:10.1101/gad.11.16.2090 · Cited by 419
You, J., Croyle, J. L., Nishimura, A., Ozato, K., & Howley, P. M. (2004) · Cell · doi:10.1016/s0092-8674(04)00402-7 · Cited by 402
Epidermal stem cells: markers, patterning and the control of stem cell fate
Watt, F. M. (1998) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1998.0247 · Cited by 400
Duensing, S., Lee, L. Y., Duensing, A., Basile, J., Piboonniyom, S.-O., Gonzalez, S., Crum, C. P., & Münger, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170093297 · Cited by 397
Mohr, I. J., Clark, R., Sun, S., Androphy, E. J., MacPherson, P., & Botchan, M. R. (1990) · Science · doi:10.1126/science.2176744 · Cited by 394
Nees, M., Geoghegan, J. M., Hyman, T., Frank, S., Miller, L., & Woodworth, C. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4283-4296.2001 · Cited by 387
Nakagawa, S., & Huibregtse, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8244-8253.2000 · Cited by 382
The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300
Patel, D., Huang, S., Baglia, L. A., & McCance, D. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5061 · Cited by 374
Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome
Cole, S. T., & Danos, O. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90343-3 · Cited by 345
Hegde, R. S., Grossman, S. R., Laimins, L. A., & Sigler, P. B. (1992) · Nature · doi:10.1038/359505a0 · Cited by 344
Self-citationInactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein.
Zerfass, K., Zwerschke, W., Mannhardt, B., Tindle, R. W., Botz, J. W., & Jansen‐Dürr, P. (1996) · PubMed · Cited by 333
Doorbar, J., Ely, S., Sterling, J., McLean, C., & Crawford, L. (1991) · Nature · doi:10.1038/352824a0 · Cited by 328
Barbosa, M. S., Edmonds, C., Fisher, C., Schiller, J. T., Lowy, D. R., & Vousden, K. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08091.x · Cited by 327
Dyson, N., Guida, P., Münger, K., & Harlow, E. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.6893-6902.1992 · Cited by 314
Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins.
Chiang, C. M., Ustav, M., Stenlund, A., Ho, T. F., Broker, T. R., & Chow, L. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5799 · Cited by 294
Atomic model of the papillomavirus capsid
Modis, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf494 · Cited by 290
Maturation of Papillomavirus Capsids
Buck, C. B., Thompson, C. D., Pang, Y.-Y. S., Lowy, D. R., & Schiller, J. T. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2839-2846.2005 · Cited by 289
Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein
Park, J.-S., Kim, E.-J., Kwon, H.-J., Hwang, E.-S., Namkoong, S.-E., & Um, S.-J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6764 · Cited by 285
Chang, Y. E., & Laimins, L. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4174-4182.2000 · Cited by 284
Self-citationZimmermann, H., Degenkolbe, R., Bernard, H.-U., & O’Connor, M. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6209-6219.1999 · Cited by 282
To die or not to die: how does p53 decide?
Slee, E. A., O'Connor, D. J., & Lu, X. (2004) · Oncogene · doi:10.1038/sj.onc.1207516 · Cited by 278
Gardiol, D., Kühne, C., Glaunsinger, B., Lee, S. S., Javier, R., & Banks, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202920 · Cited by 277
Human papillomavirus life cycle: active and latent phases
Stubenrauch, F., & Laimins, L. A. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0141 · Cited by 273
Self-citationStraight, S. W., Hinkle, P. M., Jewers, R. J., & McCance, D. J. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4521-4532.1993 · Cited by 271
Hummel, M., Hudson, J. B., & Laimins, L. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.6070-6080.1992 · Cited by 271
Self-citationHuman Pathogenic Papillomavirus Types: An Update
de Villiers, E. M. (1994) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78487-3_1 · Cited by 270
Gonzalez, S. L., Stremlau, M., He, X., Basile, J. R., & Münger, K. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7583-7591.2001 · Cited by 270
Lee, S. S., Glaunsinger, B., Mantovani, F., Banks, L., & Javier, R. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9680-9693.2000 · Cited by 268
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
Brehm, A., Nielsen, S. J., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2449 · Cited by 267
The papillomavirus E2 regulatory proteins.
McBride, A. A., Romanczuk, H., & Howley, P. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55073-0 · Cited by 266
Straight, S. W., Herman, B., & McCance, D. J. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3185-3192.1995 · Cited by 258
Clerici, M., Ferrario, E., Trabattoni, D., Villa, M. L., Clerici, E., Merola, M., Stefanon, B., De Palo, G., Venzon, D. J., & Shearer, G. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.245 · Cited by 257
Middleton, K., Peh, W., Southern, S., Griffin, H., Sotlar, K., Nakahara, T., El-Sherif, A., Morris, L., Seth, R., Hibma, M., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10186-10201.2003 · Cited by 255
Conrad, M., Bubb, V. J., & Schlegel, R. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6170-6178.1993 · Cited by 248
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors
Thorland, E. C., Myers, S. L., Gostout, B. S., & Smith, D. I. (2003) · Oncogene · doi:10.1038/sj.onc.1206170 · Cited by 248
Day, P. M., Baker, C. C., Lowy, D. R., & Schiller, J. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404229101 · Cited by 245
Danos, O., Katinka, M. D., & Yaniv, M. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01152.x · Cited by 237
Veldman, T., Horikawa, I., Barrett, J. C., & Schlegel, R. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4467-4472.2001 · Cited by 237
Jones, D. L., Thompson, D. A., & Münger, K. (1997) · Virology · doi:10.1006/viro.1997.8851 · Cited by 231
Nguyen, M. L., Nguyen, M. M., Lee, D., Griep, A. E., & Lambert, P. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6957-6964.2003 · Cited by 230
The Human Papillomavirus E7 Oncoprotein Abrogates Signaling Mediated by Interferon-α
Barnard, P., & McMillan, N. A. J. (1999) · Virology · doi:10.1006/viro.1999.9771 · Cited by 227
Flores, E. R., Allen-Hoffmann, B. L., Lee, D., & Lambert, P. F. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6622-6631.2000 · Cited by 226
Veldman, T., Liu, X., Yuan, H., & Schlegel, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1435900100 · Cited by 214
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation
Thomas, M., Laura, R., Hepner, K., Guccione, E., Sawyers, C., Lasky, L., & Banks, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205668 · Cited by 204
Pett, M. R., Alazawi, W., Roberts, I., Dowen, S. E., Smith, D. I., Stanley, M., & Coleman, N. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3214 · Cited by 204
Fehrmann, F., Klumpp, D. J., & Laimins, L. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.2819-2831.2003 · Cited by 202
Self-citationOh, S. T., Kyo, S., & Laimins, L. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5559-5566.2001 · Cited by 201
Self-citationTrus, B. L., Roden, R. B. S., Greenstone, H. L., Vrhel, M., Schiller, J. T., & Booy, F. P. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0597-413 · Cited by 195
Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein
Phelps, W. C., Münger, K., Yee, C. L., Barnes, J. A., & Howley, P. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2418-2427.1992 · Cited by 194
E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I
Ashrafi, G. H., Haghshenas, M. R., Marchetti, B., O'Brien, P. M., & Campo, M. S. (2005) · International Journal of Cancer · doi:10.1002/ijc.20558 · Cited by 192
Review: IFN- α / β Receptor Interactions to Biologic Outcomes: Understanding the Circuitry
Brierley, M. M., & Fish, E. N. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002760274845 · Cited by 190
Steger, G., & Corbach, S. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.50-58.1997 · Cited by 188
Tan, S., Leong, L. E.-C., Walker, P. A., & Bernard, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.10.6411-6420.1994 · Cited by 186
Papillomavirus polypeptides E6 and E7 are zinc-binding proteins
Barbosa, M. S., Lowy, D. R., & Schiller, J. T. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1404-1407.1989 · Cited by 184
Life Cycle Heterogeneity in Animal Models of Human Papillomavirus-Associated Disease
Peh, W. L., Middleton, K., Christensen, N. D., Nicholls, P. K., Egawa, K., Sotlar, K., Brandsma, J. L., Percival, A., Lewis, J., Liu, W. J., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.20.10401-10416.2002 · Cited by 179
Thomas, M. C., & Chiang, C.-M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.016 · Cited by 178
Bouvard, V., Storey, A., Pim, D. C., & Banks, L. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06880.x · Cited by 173
Genther, S. M., Sterling, S., Duensing, S., Münger, K., Sattler, C., & Lambert, P. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.2832-2842.2003 · Cited by 164
Longworth, M. S., & Laimins, L. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3533-3541.2004 · Cited by 163
Self-citationIdentification of the human papilloma virus‐1a E4 gene products.
Doorbar, J., Campbell, D. G., Grand, R. J., & Gallimore, P. H. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04219.x · Cited by 159
Interactions between Papillomavirus L1 and L2 Capsid Proteins
Finnen, R. L., Erickson, K. D., Chen, X. S., & Garcea, R. L. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4818-4826.2003 · Cited by 159
Gewin, L., & Galloway, D. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7198-7201.2001 · Cited by 156
Sedman, J., & Stenlund, A. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6893-6897.1998 · Cited by 155
Human Papillomavirus E7 Oncoproteins Bind a Single Form of Cyclin E in a Complex with cdk2 and p107
McIntyre, M., Ruesch, M. N., & Laimins, L. A. (1996) · Virology · doi:10.1006/viro.1996.0008 · Cited by 151
Self-citationMasterson, P. J., Stanley, M., Lewis, A. P., & Romanos, M. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7407-7419.1998 · Cited by 150
Doorbar, J., Foo, C., Coleman, N., Medcalf, L., Hartley, O., Prospero, T. D., Napthine, S., Sterling, J. C., Winter, G. P., & Griffin, H. M. (1997) · Virology · doi:10.1006/viro.1997.8768 · Cited by 150
Ma, T., Zou, N., Lin, B. Y., Chow, L. T., & Harper, J. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.382 · Cited by 141
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Hwang, E.-S., Nottoli, T., & DiMaio, D. (1995) · Virology · doi:10.1006/viro.1995.1395 · Cited by 140
Schmitt, A., Harry, J. B., Rapp, B., Wettstein, F. O., & Iftner, T. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7051-7059.1994 · Cited by 139
Frattini, M. G., & Laimins, L. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12398 · Cited by 137
Self-citationThe E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in golgi and plasma membranes
Burkhardt, A. L., Willingham, M. C., Gay, C. G., Jeang, K.-T., & Schlegel, R. (1989) · Virology · doi:10.1016/0042-6822(89)90391-7 · Cited by 132
Kim, S. K. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80088-9 · Cited by 130
Wilson, R., Fehrmann, F., & Laimins, L. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6732-6740.2005 · Cited by 127
Self-citationHuman Papillomavirus DNA Replication Compartments in a Transient DNA Replication System
Swindle, C. S., Zou, N., Tine, B. A. V., Shaw, G. M., Engler, J. A., & Chow, L. T. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1001-1009.1999 · Cited by 127
Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo
Um, S., Rhyu, J.-W., Kim, E.-J., Jeon, K.-C., Hwang, E.-S., & Park, J. S. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00871-0 · Cited by 126
Human Papillomavirus DNA Replication
Conger, K. L., Liu, J., Kuo, S., Chow, L. T., & Wang, T. S. ‐. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2696 · Cited by 126
Lee, C., & Laimins, L. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12366-12377.2004 · Cited by 125
Self-citationCervical cancer control, priorities and new directions
Monsonégo, J., Bosch, F. X., Coursaget, P., Cox, J. T., Franco, E. L., Frazer, I. H., Sankaranarayanan, R., Schiller, J. T., Singer, A., Wright, T., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11530 · Cited by 125
A human papilloma virus type 11 transcript encoding an E1^E4 protein
Nasseri, M., Hirochika, R., Broker, T. R., & Chow, L. T. (1987) · Virology · doi:10.1016/0042-6822(87)90482-x · Cited by 124
Massimi, P., Gammoh, N., Thomas, M., & Banks, L. (2004) · Oncogene · doi:10.1038/sj.onc.1207977 · Cited by 124
Baxter, M. K., McPhillips, M. G., Ozato, K., & McBride, A. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4806-4818.2005 · Cited by 121
Stöppler, H., Hartmann, D.-P., Sherman, L., & Schlegel, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13332 · Cited by 118
Duensing, S. M., Duensing, A. U., Flores, E. R., Do, A., Lambert, P. F., & Münger, K. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7712-7716.2001 · Cited by 118
Wang, Q., Griffin, H. M., Southern, S. A., Jackson, D. J., Martin, A., McIntosh, P. B., Davy, C. E., Masterson, P. J., Walker, P. A., Laskey, P., et al. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.821-833.2004 · Cited by 118
Crusius, K., Auvinen, E., Steuer, B., Gaissert, H., & Alonso, A. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4024 · Cited by 118
Nguyen, M. M., Nguyen, M. L., Caruana, G., Bernstein, A., Lambert, P. F., & Griep, A. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.8970-8981.2003 · Cited by 114
Hwang, S. G., Lee, D., Kim, J., Seo, T., & Choe, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109113200 · Cited by 111
Binding of the E1 and E2 proteins to the origin of replication of bovine papillomavirus
Sedman, T., Sedman, J., & Stenlund, A. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2887-2896.1997 · Cited by 110
Berezutskaya, E., Yu, B., Morozov, A., Raychaudhuri, P., & Bagchi, S. (1997) · PubMed · Cited by 110
Bouvard, V., Matlashewski, G., Gu, Z.-M., Storey, A., & Banks, L. (1994) · Virology · doi:10.1006/viro.1994.1456 · Cited by 110
Identification of a G 2 Arrest Domain in the E1∧E4 Protein of Human Papillomavirus Type 16
Davy, C. E., Jackson, D. J., Wang, Q., Raj, K., Masterson, P. J., Fenner, N. F., Southern, S. A., Cuthill, S., Millar, J. B. A., & Doorbar, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.9806-9818.2002 · Cited by 109
Zhang, B., Li, P., Wang, E., Brahmi, Z., Dunn, K. W., Blum, J. S., & Roman, A. (2003) · Virology · doi:10.1016/s0042-6822(03)00103-x · Cited by 108
Structure of the intact transactivation domain of the human papillomavirus E2 protein
Antson, A. A., Burns, J. E., Moroz, O. V., et al. (2000) · Nature · doi:10.1038/35001638 · Cited by 107
Al‐Saleh, W., Giannini, S. L., Jacobs, N., Moutschen, M. P., Doyen, J., Boniver, J., & Delvenne, P. (1998) · The Journal of Pathology · Cited by 106
Kazemi, S., Papadopoulou, S., Li, S., Su, Q., Wang, S., Yoshimura, A., Matlashewski, G., Dever, T. E., & Koromilas, A. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3415-3429.2004 · Cited by 104
Loo, Y., & Melendy, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1605-1615.2004 · Cited by 104
The integration of HPV-18 DNA in cervical carcinoma.
Corden, S. A., Sant‐Cassia, L. J., Easton, A. J., & Morris, A. G. (1999) · Molecular Pathology · doi:10.1136/mp.52.5.275 · Cited by 102
Reorganization of Nuclear Domain 10 Induced by Papillomavirus Capsid Protein L2
Florin, L., Schäfer, F., Sotlar, K., Streeck, R. E., & Sapp, M. J. (2002) · Virology · doi:10.1006/viro.2002.1360 · Cited by 101
Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes
Danos, O., Engel, L. W., Chen, E. Y., Yaniv, M., & Howley, P. M. (1983) · Journal of Virology · doi:10.1128/jvi.46.2.557-566.1983 · Cited by 100
The Structural Basis of DNA Target Discrimination by Papillomavirus E2 Proteins
Kim, S., Tam, J. K., Wang, A.-F., & Hegde, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004541200 · Cited by 97
HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs
Longworth, M. S., Wilson, R., & Laimins, L. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600651 · Cited by 96
Self-citationDarshan, M. S., Lucchi, J., Harding, E. E., & Moroianu, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12179-12188.2004 · Cited by 93
Duensing, S., & Münger, K. (2003) · Journal of Virology · doi:10.1128/jvi.77.22.12331-12335.2003 · Cited by 91
Patrick, D. R., Oliff, A. I., & Heimbrook, D. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37452-5 · Cited by 90
Lee, D., Lee, B., Kim, J., Kim, D. W., & Choe, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7045 · Cited by 90
Stubenrauch, F., Lim, H. B., & Laimins, L. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1071-1077.1998 · Cited by 90
Self-citationValle, G. F., & Banks, L. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-5-1239 · Cited by 90
The Role of the E1 and E2 Proteins in the Replication of Human Papillomavirus Type 31b
Frattini, M. G., & Laimins, L. A. (1994) · Virology · doi:10.1006/viro.1994.1596 · Cited by 89
Self-citationModulation of the Cell Division Cycle by Human Papillomavirus Type 18 E4
Nakahara, T., Nishimura, A., Tanaka, M., Ueno, T., Ishimoto, A., & Sakai, H. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10914-10920.2002 · Cited by 87
Sapp, M. J., Volpers, C., Müller, M., & Streeck, R. E. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-9-2407 · Cited by 86
Zhang, B., Spandau, D. F., & Roman, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.220-231.2002 · Cited by 85
Cyclin/CDK Regulates the Nucleocytoplasmic Localization of the Human Papillomavirus E1 DNA Helicase
Deng, W., Lin, B. Y., Jin, G., Wheeler, C. G., Ma, T., Harper, J. W., Broker, T. R., & Chow, L. T. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13954-13965.2004 · Cited by 82
Crusius, K., Auvinen, E., & Alonso, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201312 · Cited by 81
Davy, C. E., Jackson, D. J., Raj, K., Peh, W. L., Southern, S. A., Das, P., Sorathia, R., Laskey, P., Middleton, K., Nakahara, T., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.3998-4011.2005 · Cited by 80
Favre-Bonvin, A., Reynaud, C., Kretz‐Remy, C., & Jalinot, P. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.4229-4237.2005 · Cited by 77
Klumpp, D. J., & Laimins, L. A. (1999) · Virology · doi:10.1006/viro.1999.9636 · Cited by 76
Self-citationReplication of human papillomavirus (HPV) DNAs supported by the HPV type 18 E1 and E2 proteins
Sverdrup, F. M., & Khan, S. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.505-509.1994 · Cited by 75
Hadaschik, D., Hinterkeuser, K., Ołdak, M., Pfister, H., & Smola, S. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5253-5265.2003 · Cited by 75
Disbrow, G. L., Hanover, J. A., & Schlegel, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5839-5846.2005 · Cited by 72
Nguyen, D. X., Westbrook, T. F., & McCance, D. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.619-632.2002 · Cited by 71
The HPV16 E5 oncogene inhibits endocytic trafficking
Thomsen, P., van Deurs, B., Norrild, B., & Kayser, L. (2000) · Oncogene · doi:10.1038/sj.onc.1204010 · Cited by 69
Nagasaka, K., Nakagawa, S., Yano, T., Takizawa, S., Matsumoto, Y., Tsuruga, T., Nakagawa, K., Minaguchi, T., Oda, K., Hiraike‐Wada, O., et al. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00315.x · Cited by 68
Ruesch, M. N., & Laimins, L. A. (1998) · Virology · doi:10.1006/viro.1998.9359 · Cited by 67
Self-citationDoorbar, J., Elston, R. C., Napthine, S., Raj, K., Medcalf, E., Jackson, D. J., Coleman, N., Griffin, H. M., Masterson, P. J., Stacey, S., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10081-10095.2000 · Cited by 66
Global Effects of Human Papillomavirus Type 18 E6/E7 in an Organotypic Keratinocyte Culture System
Garner-Hamrick, P. A., Fostel, J. M., Chien, W., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9041-9050.2004 · Cited by 64
Inhibition of Human Papillomavirus Type 16 E7 Phosphorylation by the S100 MRP-8/14 Protein Complex
Tugizov, S. M., Berline, J. W., Herrera, R., Peñaranda, M. E., Nakagawa, M., & Palefsky, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.1099-1112.2005 · Cited by 63
Effect of human papillomavirus type 16 oncogenes on MAP kinase activity
Gu, Z., & Matlashewski, G. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.8051-8056.1995 · Cited by 62
Nuclear Import Strategies of High Risk HPV16 L1 Major Capsid Protein
Nelson, L. M., Rose, R. C., & Moroianu, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200724200 · Cited by 53
Differential Phosphorylation of the HPV-16 E7 Oncoprotein during the Cell Cycle
Massimi, P., & Banks, L. (2000) · Virology · doi:10.1006/viro.2000.0514 · Cited by 48
Huang, P. S., Patrick, D. R., Edwards, G., Goodhart, P. J., Huber, H. E., Miles, L., Garsky, V. M., Oliff, A., & Heimbrook, D. C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.953 · Cited by 47
Functional Interaction between p/CAF and Human Papillomavirus E2 Protein
Lee, D., Hwang, S. G., Kim, J., & Choe, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105085200 · Cited by 45
Human papillomavirus type 16 in head and neck carcinogenesis
Chen, R., Aaltonen, L., & Vaheri, A. I. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.471 · Cited by 41
Tissue Effects of and Host Response to Human Papillomavirus Infection
Jenson, A. B., Kurman, R. J., & Lancaster, W. D. (1991) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30410-8 · Cited by 40
Kanaya, T., Kyo, S., & Laimins, L. A. (1997) · Virology · doi:10.1006/viro.1997.8771 · Cited by 40
Self-citationBecker, K. A., Florin, L., Sapp, C., Maul, G. G., & Sapp, M. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1121-1128.2004 · Cited by 36
(1993) · PubMed
(1996) · PubMed
Cited by
Establishment of human papillomavirus infection requires cell cycle progression
Pyeon, D., Pearce, S. M., Lank, S. M., Ahlquist, P., & Lambert, P. F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000318 · Cited by 348
Lazarczyk, M., Cassonnet, P., Pons, C., Jacob, Y., & Favre, M. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00033-08 · Cited by 131
Morgan, I., DiNardo, L., & Windle, B. (2017) · Viruses · doi:10.3390/v9080208 · Cited by 65
Low- and high-risk human papillomavirus E7 proteins regulate p130 differently
Barrow-Laing, L., Chen, W., & Roman, A. (2010) · Virology · doi:10.1016/j.virol.2010.01.034 · Cited by 39
McLaughlin-Drubin, M., & Munger, K. (2013) · Viruses · doi:10.3390/v5051231 · Cited by 28
Metadata
- Authors
- Hebner, C. M., & Laimins, L. A.
- Venue
- Reviews in Medical Virology
- Publisher
- Wiley
- Published
- 2005-11-15
- Volume
- 16
- Issue
- 2
- Pages
- 83-97
- ISSN
- 1052-9276 (ISSN-L)
- 1099-1654
- OpenAlex
- W2100448174
- Cited by
- 401
- References
- 161
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.